ATLAS / Macro Radar / Reporting / PLX

Protalix BioTherapeutics, Inc. (PLX) reporting calendar

Protalix BioTherapeutics, Inc. files periodic reports with the SEC as PLX on NYSE. Atlas tracks 90 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
90

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open PLX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001104659-26-059756
10-K31 Dec 202518 Mar 202677 days0001104659-26-029858
10-Q30 Sep 202513 Nov 202544 days0001104659-25-110824
10-Q30 Jun 202514 Aug 202545 days0001558370-25-011471
10-Q31 Mar 20259 May 202539 days0001558370-25-007063
10-K31 Dec 202417 Mar 202576 days0001558370-25-003039
10-Q30 Sep 202414 Nov 202445 days0001558370-24-015612
10-Q30 Jun 202414 Aug 202445 days0001558370-24-012134
10-Q31 Mar 202410 May 202440 days0001558370-24-007695
10-K31 Dec 202314 Mar 202474 days0001558370-24-003161
10-Q30 Sep 20236 Nov 202337 days0001558370-23-017664
10-Q30 Jun 20237 Aug 202338 days0001558370-23-013483
10-Q31 Mar 20234 May 202334 days0001558370-23-008132
10-K31 Dec 202227 Feb 202358 days0001558370-23-002102
10-Q30 Sep 202214 Nov 202245 days0001558370-22-017554
10-Q30 Jun 202215 Aug 202246 days0001558370-22-013560
10-Q31 Mar 202216 May 202246 days0001558370-22-008847
10-K31 Dec 202131 Mar 202290 days0001558370-22-004823
10-Q30 Sep 202115 Nov 202146 days0001558370-21-015862
10-Q30 Jun 202116 Aug 202147 days0001558370-21-011752
10-Q31 Mar 202114 May 202144 days0001558370-21-007157
10-K31 Dec 202030 Mar 202189 days0001558370-21-003681
10-Q30 Sep 202029 Oct 202029 days0001558370-20-011974
10-Q30 Jun 202010 Aug 202041 days0001104659-20-092375
10-Q31 Mar 20201 Jun 202062 days0001104659-20-067982
10-K31 Dec 201912 Mar 202072 days0001104659-20-032540
10-Q30 Sep 20197 Nov 201938 days0001104659-19-060804
10-Q30 Jun 20198 Aug 201939 days0001144204-19-038552
10-Q31 Mar 20196 May 201936 days0001144204-19-023895
10-K31 Dec 201818 Mar 201977 days0001144204-19-014464
10-Q30 Sep 20187 Nov 201838 days0001144204-18-057990
10-Q30 Jun 20189 Aug 201840 days0001144204-18-043286
10-Q31 Mar 20189 May 201839 days0001144204-18-026625
10-K31 Dec 20176 Mar 201865 days0001144204-18-013053
10-Q30 Sep 20178 Nov 201739 days0001144204-17-057290
10-Q30 Jun 20179 Aug 201740 days0001144204-17-041693
10-Q31 Mar 201710 May 201740 days0001144204-17-026034
10-K31 Dec 201616 Mar 201775 days0001144204-17-015083
10-Q30 Sep 20169 Nov 201640 days0001144204-16-132819
10-Q30 Jun 20168 Aug 201639 days0001144204-16-117287

Source: SEC EDGAR company submissions for CIK 0001006281. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.